Comparing two types of ultrasound for patients with viral hepatitis

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study compares the effectiveness of conventional ultrasound (CUS) and ultraportable ultrasound with teleradiology capabilities (TUP) in patients diagnosed with viral hepatitis. The primary objective is to assess the performance of both ultrasound methods based on specific imaging criteria. Additionally, the study will evaluate patient satisfaction, comfort, and the reproducibility of the ultraportable ultrasound's use. By analyzing these factors, the study aims to determine which method provides better diagnostic outcomes.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Informed Consent signed by the subject
* All adult patients with viral hepatitis for which an ultrasound is planned

Exclusion Criteria:

* Known or suspected non-compliance
* Inability to follow the procedures of the study, e.g. due to language problems, psychological disorders, dementia, etc. of the participant,
* Previous enrollment into the current study

Where it's running

• Lausanne University Hospital
  Lausanne, Canton of Vaud, Switzerland Recruiting

Study contacts

• Study coordinator: Naïk Vietti Violi, MD
• Email: naik.vietti-violi@chuv.ch
• Phone: +41795560240

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• ePro Diary for people with HDV (MACROLIVER)

  This project will try a mobile ePro diary app to help adults with Delta hepatitis (HDV) track symptoms and share health information with their care team.

  Recruiting FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS · Bergamo, Italy · NCT07442760

• Larsucosterol for people with severe alcohol-associated hepatitis

  This trial will test whether larsucosterol helps people with severe alcohol-associated hepatitis survive 90 days without needing a liver transplant.

  Recruiting at 37 sites Phase 3 Bausch Health Americas, Inc. · Birmingham, Alabama and 91 other locations · NCT07428538

• Investigating symptoms and blood test characteristics of acute hepatitis in children

  This study is trying to learn more about the symptoms and blood test results of children with acute hepatitis to help doctors recognize and manage the condition better.

  Recruiting at 2 sites IRCCS Azienda Ospedaliero-Universitaria di Bologna · Bologna and 1 other locations · NCT06761261

• Low dead-space syringe and needle distribution for people who inject drugs in low- and middle-income countries

  This program will test whether offering low dead-space syringes and needles to people who inject drugs at needle and syringe programs in several low- and middle-income countries increases acceptability and use of safer injecting equipment.

  Recruiting at 9 sites Médecins du Monde · Yerevan and 8 other locations · NCT06395129

• Evaluating HepaCure for treating acute-on-chronic liver failure in Chinese patients

  This study is testing if a new liver support system called HepaCure, used with another treatment, can help Chinese patients with acute-on-chronic liver failure feel better compared to using the other treatment alone.

  Recruiting Phase 1/2 Hexaell Biotech Co., Ltd. · Beijing, Beijing Municipality · NCT05989958

• Evaluating TYNADOTE® for treating acetaminophen overdose

  This study is testing if TYNADOTE® can help people who have overdosed on acetaminophen feel better and recover more effectively when given alongside standard treatment.

  Recruiting Phase 2 Sinew Pharma Inc. · Taipei, Beitou District · NCT05557448

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.